Depreciation of Cartesian Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cartesian Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Cartesian Therapeutics, Inc. Depreciation for the quarter ending 31 Dec 2025 was $600,000, a 20% increase year-over-year.
  • Cartesian Therapeutics, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $2,400,000, a 100% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Depreciation for 2025 was $2,400,000, a 100% increase from 2024.
  • Cartesian Therapeutics, Inc. annual Depreciation for 2024 was $1,200,000, a 71% increase from 2023.
  • Cartesian Therapeutics, Inc. annual Depreciation for 2023 was $700,000, unchanged from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Cartesian Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,400,000 $600,000 +$100,000 +20% 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $2,300,000 $600,000 +$300,000 +100% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $2,000,000 $600,000 +$400,000 +200% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,600,000 $600,000 +$400,000 +200% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,200,000 $500,000 +$300,000 +150% 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $900,000 $300,000 +$200,000 +200% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $700,000 $200,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $700,000 $200,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $700,000 $200,000 $0 0% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $700,000 $100,000 -$100,000 -50% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $800,000 $200,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $800,000 $200,000 +$100,000 +100% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $700,000 $200,000 $0 0% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $700,000 $200,000 +$100,000 +100% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $600,000 $200,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 17 Aug 2023 2023 Q2
Q1 2022 $600,000 $100,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $600,000 $200,000 +$100,000 +100% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
Q3 2021 $500,000 $100,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $500,000 $200,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $500,000 $100,000 -$100,000 -50% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $600,000 $100,000 -$19,000 -16% 01 Oct 2020 31 Dec 2020 10-K 02 Mar 2023 2022 FY
Q3 2020 $619,000 $100,000 -$100,000 -50% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $719,000 $200,000 $0 0% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $719,000 $200,000 +$19,000 +10% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $700,000 $119,000 -$112,000 -48% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
Q3 2019 $812,000 $200,000 $0 0% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $812,000 $200,000 -$200,000 -50% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $1,012,000 $181,000 +$12,000 +7.1% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $1,000,000 $231,000 +$81,000 +54% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
Q3 2018 $919,000 $200,000 $0 0% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $919,000 $400,000 +$200,000 +100% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $719,000 $169,000 -$31,000 -16% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $750,000 $150,000 -$174,000 -54% 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
Q3 2017 $924,000 $200,000 +$100,000 +100% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $824,000 $200,000 $0 0% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $824,000 $200,000 +$22,000 +12% 01 Jan 2017 31 Mar 2017 10-Q 08 Aug 2018 2018 Q2
Q4 2016 $802,000 $324,000 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2019 2018 Q4
Q3 2016 $100,000 -$100,000 -50% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $200,000 -$300,000 -60% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $178,000 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q3 2015 $200,000 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $500,000 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2

Cartesian Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,400,000 +$1,200,000 +100% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $1,200,000 +$500,000 +71% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $700,000 $0 0% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $700,000 +$100,000 +17% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $600,000 $0 0% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
2020 $600,000 -$100,000 -14% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023 2022 FY
2019 $700,000 -$300,000 -30% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
2018 $1,000,000 +$250,000 +33% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
2017 $750,000 -$52,000 -6.5% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $802,000 -$242,000 -23% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2019 2018 Q4
2015 $1,044,000 +$180,000 +21% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018 2017 Q4
2014 $864,000 01 Jan 2014 31 Dec 2014 10-K 28 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.